RT Journal Article SR Electronic T1 Putting (Big) Data in Action: Saving Lives with Countrywide Population Movement Monitoring Using Mobile Devices during the COVID‐19 Crisis JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.09.21.20194019 DO 10.1101/2020.09.21.20194019 A1 Szocska, Miklos A1 Pollner, Peter A1 Schiszler, Istvan A1 Joo, Tamas A1 Palicz, Tamas A1 McKee, Martin A1 Telekom Nyrt., Magyar A1 Magyarorszag Zrt., Telenor A1 Sohonyai, Adam A1 Szoke, Jozsef A1 Toth, Adam A1 Gaal, Peter YR 2020 UL http://medrxiv.org/content/early/2020/09/23/2020.09.21.20194019.abstract AB Many countries have implemented strict social distancing measures in the hope of reducing transmission of SARS-CoV-2 but the effectiveness of these measures is determined by the willingness of populations to comply with restrictions. Consequently, a system of monitoring population movement using existing data sources can inform those making decisions about policy responses to the COVID-19 pandemic.We describe a collaboration with all 3 major domestic telecommunication companies in Hungary to use aggregated anonymous mobile phone usage data to calculate two indices for assessing the effect of movement restrictions: a “mobility-index” and a “stay-at-home (or resting) index”. The strengths and weaknesses of this approach are compared with the smartphone-based, COVID-19 Community Mobility Reports from Google.Data generated by mobile phones have long been identified as a potential means to analyse mass population movement, but its operationalisation raises several technical questions, such as making sense of Call Detail Records, collation of data from different mobile network providers, and personal data protection concerns. The method described here addresses these issues and offers an effective and inexpensive tool to monitor the impact of social distancing measures, achieving high levels of accuracy and resolution. Especially in populations where uptake of smartphones is modest, this method has certain advantages over app-based solutions, with greater population coverage, but it is not an alternative to smartphone-based solutions used for contact tracing and quarantine monitoring. We believe that this method can easily be adapted by other countries.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/AFunding StatementSemmelweis University is a government funded public institution. A specific grant supported the operation of the DHDUT from the National Research, Development and Innovation Fund (grant no. 2020-2.1.1-ED-2020-00003), and another grant of the Hungarian National Research, Development and Innovation Office also supported the research (grant no. K 128780). The research was partially financed by the Research Excellence Programme of the Ministry for Innovation and Technology in Hungary, within the framework of the Digital Biomarker thematic programme of the Semmelweis University. MT, TM and Vodafone Hungary provided the datasets and their expertise free of charge. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study needed no approval, because it is the secondary analysis of anonymous big data aggregated at the level of Hungarian settlements over 24h periods. Therefore the subjects of the study are Hungarian settlements, not individual subscribers, who were (are) impossible to be identified, and from whom it was not possible to obtain consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data available at Harvard Dataverse as Hun Covid Mobile Dataset. https://doi.org/10.7910/DVN/IPJULW